COVID-19 and Heart Disease: The “Pharma” Perspective
ESC Cardiovascular Round Table – COVID-19 special Presented by Dr David Soergel – Novartis, Switzerland.
European Society of Cardiology
New and Emerging Therapies for Heart Failure | Gregg Fonarow, MD
Heart Failure Update UCLA Heart Failure Symposium 2013.
UCLA Health
Mechanism(s) of ACE inhibitors, ARBs, and ARB/NEP Inhibitors
Moser Memorial Lecture Dean Nancy Brown discusses the appropriate use of ACE inhibitors, ARBs, and NEP/ARB. Talk begins: ...
Yale Cardiovascular Medicine
ACE Inhibitors: a Double-edged Sword
Dr. Mimi Lam, MetroHealth Medical Center.
CaseMed Minute
Clinical Trial Conference Series: FSGS
Glomerular Disease Study & Trial Consortium
Medicine Today - Ep. 7 - ST-Segment Elevation Myocardial Infarction
This ST-Segment Elevation Myocardial Infarction webcast, from the 23rd Annual Intensive Review of Internal Medicine Symposium, describes the initial ...
ClevelandClinicCME
Whats New in PKD 2015: Cardiovascular Issues and Cardiac Valve Abnormalities
As you manage living with PKD, keeping your heart healthy is very important to overall health. Learn about the issues that could affect your heart and how you ...
PKDFoundation
DAPA HF & PARAGON HF A Tale of Two Diseases - Dr. Amr Gamal Shawky
Journal Club 2/10/2019.
Cardiology Department Ain Shams
Cardiovascular Prevention in the Asymptomatic Diabetic Patient
Cardiology Conference hosted by: Sunil V. Rao, MD FACC Assistant Professor of Medicine Director, Cardiac Catheterization Laboratories Durham VA Medical ...
Duke Clinical Research Institute
Guidelines for Heart Failure Medical Therapy
Andrew Lenneman, MD, discusses what is new in medical management of heart failure.
UAB Medicine
Dr. Dinesh Thavendiranathan: "The Emerging Epidemic: Cancer and Heart Failure"
Ted Rogers Centre for Heart Research 1st Scientific Symposium presentation: Dr. Thavendiranathan leads the Ted Rogers Program in Cardiotoxicity Prevention ...
Ted Rogers Centre for Heart Research
The HALT-PKD Study: What Do the Results of this Study Mean for Me?
Presented by Ronald D. Perrone, M.D., HALT study principal investigator This webinar shared the results of the HALT-PKD clinical trials, which were announced ...
PKDFoundation
Adventures in Cardiovascular Research by Eugene Braunwald, MD
CWRU Medicine
What's New in PKD: Research and Clinical Trials
In March, local PKD chapters participated in the PKD Foundation's first ever online educational conference. Experts in PKD presented live to chapters from ...
PKDFoundation
CHF Update 6/1/16
MGMC Physician Grand Rounds, 6/1/16 Rakshak Sarda, MD, Cardiology Iowa Heart Center.
Mary Greeley Medical Center
A new drug for a dual blockade of the RAAS in cardiac dogs (3/4) - Use of the combination
This session presents the main clinical benefits and safety data of a new drug combining 2 actives for heart failure treatment in dogs.
CardioAcademy Cevalearn
New Insights into the Diagnosis and Treatment of AKI in Patients with Acute Decompensated HF
A Division of Hospital Medicine Grand Rounds presented by Steven Coca, DO, MS, Associate Chair for Clinical and Translational Research, Department of ...
Icahn School of Medicine
Recent Highlights in Cardiovascular Anesthesia - Implications for Us All (Augoustides, MD) 2/06/20
LIVESTREAM RECORDING February 6, 2020 HMDHVC GRAND ROUNDS CONFERENCE "Recent Highlights in Cardiovascular Anesthesia - Implications for ...
Houston Methodist DeBakey CV Education
Renin Angiotensin Aldosterone System
This animation focuses on the renin angiotensin aldosterone system (RAAS), a classic endocrine system that helps to regulate long-term blood pressure and ...
Mechanisms in Medicine
New Agents for Heart Failure: Ivabradine
Ivabradine, an f-channel inhibitor that slows heart rate in patients with heart failure with reduced ejection fraction, significantly reduces the frequency of ...
Annenberg Center for Health Sciences
A Brief History of Heart Failure and What it can Teach us about the Future
Tariq Ahmad, MD DCRI Cardiology Research Fellow.
Duke Clinical Research Institute
Pier Lambiase, EHRA 2019 – Sudden Death Risk in Non-ischaemic Cardiomyopathy
Professor Pier Lambiase (Consultant Electrophysiologist, University College London and Barts Heart Centre, London, UK) joins touchCARDIO at the annual ...
Touch Medical Media
Hot Issues in Nephrology: RAS system in COVID 19 Era Prof Hussein Sheashaa, 15 May 2020
Hot Issues in Nephrology. RAS system and the use of RAAS Inhibitors in COVID-19 Era. Prof. Hussein Sheashaa, 15 May 2020 ESNT-CME Distance Learning ...
Academy of Kidney Diseases and Transplantation
Medical Management of Abdominal Aortic Aneurysm (Jason Lee, MD)
Houston Methodist DeBakey Heart & Vascular Center DeBakey Institute for Cardiovascular Education & Training Cardiovascular Fellows' Bootcamp 2015 ...
Houston Methodist DeBakey CV Education
International Academy of Cardiology: A.H. Jan Danser, M.D.: DUAL RENIN-ANGIOTENSIN-ALDOSTERONE
DUAL RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION: TOO MUCH OF A GOOD THING? A.H. Jan Danser, M.D. Rotterdam, The Netherlands ...
Cardiology Online
ESC Congress 2012: Future targets in Systolic Heart Failure Management
Future targets in Systolic Heart Failure Management: pharmacological therapy, new artificials hearts, complete cardiac regeneration therapies and upcoming ...
European Society of Cardiology
A new drug for a dual blockade of the RAAS in dogs (2/4) - Efficacy of Spironolactone and Benazepril
This session presents the main clinical benefits and safety data of a new drug combining 2 actives for heart failure treatment in dogs.
CardioAcademy Cevalearn
Aldosterone Blockade: Past and Future
Gerhard Hindricks, director of the Department of Electrophysiology Leipzig University Heart Center, speaks with Bertram Pitt, Professor of Medicine Emeritus at ...
Oxford Academic (Oxford University Press)
Heart failure with preserved ejection fraction
Dr. Ajith Nair presenting at the 7th Annual Women's Heart & Vascular Symposium hosted by the Texas Heart Institute Center for Women's Heart & Vascular ...
Texas Heart Institute
Atenolol vs Losartan in Patients with Marfan Syndrome
Mayo Clinic fellow, Division of Cardiovascular Diseases Robert Widmer, M.D., Ph.D., and Juan Bowen, M.D., director of the Marfan and Thoracic Aorta Clinic talk ...
Mayo Clinic
Pregnancy and Heart Disease: What Practitioner Needs to Know (CAROLE A. WARNES, MD) February 1, 2018
Pregnancy and Heart Disease: What the Practitioner Needs to Know” Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference ...
Houston Methodist DeBakey CV Education
Whats New in PKD 2015: Hypertension and HALT PKD Study Results
Uncontrolled high blood pressure can further damage and scar the kidney and is also a risk factor for heart disease. The HALT-PKD study provides important ...
PKDFoundation
Addressing the Disease Burden Associated With Anemia of Chronic Kidney Disease
Chair, Matthew R. Weir, MD, discusses anemia in CKD in this CME/CPE activity titled “Addressing the Disease Burden Associated With Anemia of Chronic ...
PeerView CME
What is the Atenolol vs Losartan clinical trial and when will the results be ready?
Ronald V. Lacro, is Director of the Cardiovascular Genetics Clinic and Marfan Syndrome Program at Children's Hospital Boston, and Associate in Cardiology at ...
The Marfan Foundation
“Cardiovascular Disease Before and After Kidney Transplantation” by Matthew Weir, MD
Grand Round presentation at University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Department of Medicine ...
CWRU Medicine
Mineralocorticoid Receptor Antagonists
Mineralocorticoid Receptor Antagonists An Opportunity for a Further Reduction in Cardiovascular Events Bertram Pitt, MD Professor of Internal Medicine ...
Duke Clinical Research Institute
Managing Comorbidities in PD Patients: Hypertension & CHF by Rajnish Mehrotra, MD
Visit http://bit.ly/DialysisOptions for more information on DaVita's dialysis treatment options. Cardiovascular disease is a significant cause of morbidity in dialysis ...
DaVita Kidney Care
Update on Novel Therapies for Heart Failure (Milton Packer, MD) February, 10, 2017
Houston Methodist DeBakey Heart & Vascular Center Update on Novel Therapies for Heart Failure Milton Packer, MD 2nd Annual Houston Heart Failure ...
Houston Methodist DeBakey CV Education
Impact Slides: PARADIGM-HF With Clyde Yancy, MD
Full story on MedPage Today: http://www.medpagetoday.com/Cardiology/CHF/50620 Why might adding a neprilysin inhibitor to an angiotensin II receptor ...
MedPage Today
Congestive Heart Failure Version 1
Created by world-class clinical faculty, Learning in 10 (LIT) Reviews covers topics in the United States Medical Licensing Exam (USMLE) Step 2CK examination.
Learning in 10
Dr. Michael McDonald: What is heart failure and how common is it?
This presentation was part of the Ted Rogers Centre 2019 Heart Failure Symposium, on May 4, 2019. Part of Canada's largest meeting devoted to heart failure, ...
Ted Rogers Centre for Heart Research
Heart Failure Guidelines and Program
Sumanth Prabhu, MD, director of the division of cardiovascular disease, and Jose Tallaj, MD, professor of medicine in the division of cardiovascular disease ...
UAB Medicine
